RENAL VASCULITIS IN 2012 Reclassification and the introduction of biologicals

Cees G. M. Kallenberg

doi:10.1038/nrneph.2012.284

RENAL VASCULITIS IN 2012 Reclassification and the introduction of biologicals

Cees G. M. Kallenberg^*

^*Corresponding author voor dit werk

Translational Immunology Groningen (TRIGR)

Onderzoeksoutput › Academic › peer review

3 Citaten (Scopus)

Samenvatting

2012 saw the classification of the systemic vasculitides revised. Genetic studies showed that granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are different diseases with aberrant immune responses to different autoantigens. B-cell depletion with rituximab also acquired a primary role in the treatment of GPA and MPA, as well as in cryoglobulinaemic vasculitis. Kallenberg, C. G. M. Nat. Rev. Nephrol. 9, 70-72 (2013); published online 8 January 2013; doi:10.1038/nrneph.2012.284

Originele taal-2	English
Pagina's (van-tot)	70-72
Aantal pagina's	3
Tijdschrift	Nature Reviews Nephrology
Volume	9
Nummer van het tijdschrift	2
DOI's	https://doi.org/10.1038/nrneph.2012.284
Status	Published - feb.-2013

Toegang tot document

10.1038/nrneph.2012.284

Handle.net

Permanente koppeling

Citeer dit

@article{32452b9ad2fb44a1a439be41f6cc19dc,

title = "RENAL VASCULITIS IN 2012 Reclassification and the introduction of biologicals",

abstract = "2012 saw the classification of the systemic vasculitides revised. Genetic studies showed that granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are different diseases with aberrant immune responses to different autoantigens. B-cell depletion with rituximab also acquired a primary role in the treatment of GPA and MPA, as well as in cryoglobulinaemic vasculitis. Kallenberg, C. G. M. Nat. Rev. Nephrol. 9, 70-72 (2013); published online 8 January 2013; doi:10.1038/nrneph.2012.284",

keywords = "ANCA-ASSOCIATED VASCULITIS, ANTIBODY-ASSOCIATED VASCULITIS, DAILY ORAL CYCLOPHOSPHAMIDE, REMISSION INDUCTION, RANDOMIZED-TRIAL, RITUXIMAB, MAINTENANCE, PULSE",

author = "Kallenberg, {Cees G. M.}",

year = "2013",

month = feb,

doi = "10.1038/nrneph.2012.284",

language = "English",

volume = "9",

pages = "70--72",

journal = "Nature Reviews Nephrology",

issn = "1759-5061",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - RENAL VASCULITIS IN 2012 Reclassification and the introduction of biologicals

AU - Kallenberg, Cees G. M.

PY - 2013/2

Y1 - 2013/2

N2 - 2012 saw the classification of the systemic vasculitides revised. Genetic studies showed that granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are different diseases with aberrant immune responses to different autoantigens. B-cell depletion with rituximab also acquired a primary role in the treatment of GPA and MPA, as well as in cryoglobulinaemic vasculitis. Kallenberg, C. G. M. Nat. Rev. Nephrol. 9, 70-72 (2013); published online 8 January 2013; doi:10.1038/nrneph.2012.284

AB - 2012 saw the classification of the systemic vasculitides revised. Genetic studies showed that granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are different diseases with aberrant immune responses to different autoantigens. B-cell depletion with rituximab also acquired a primary role in the treatment of GPA and MPA, as well as in cryoglobulinaemic vasculitis. Kallenberg, C. G. M. Nat. Rev. Nephrol. 9, 70-72 (2013); published online 8 January 2013; doi:10.1038/nrneph.2012.284

KW - ANCA-ASSOCIATED VASCULITIS

KW - ANTIBODY-ASSOCIATED VASCULITIS

KW - DAILY ORAL CYCLOPHOSPHAMIDE

KW - REMISSION INDUCTION

KW - RANDOMIZED-TRIAL

KW - RITUXIMAB

KW - MAINTENANCE

KW - PULSE

U2 - 10.1038/nrneph.2012.284

DO - 10.1038/nrneph.2012.284

M3 - Editorial

SN - 1759-5061

VL - 9

SP - 70

EP - 72

JO - Nature Reviews Nephrology

JF - Nature Reviews Nephrology

IS - 2

ER -

RENAL VASCULITIS IN 2012 Reclassification and the introduction of biologicals

Samenvatting

Toegang tot document

Handle.net

Vingerafdruk

Citeer dit